fulvestrant has been researched along with moexipril in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
de Jager, T; Muck, J; Neyses, L; Pelzer, T; Stimpel, M | 1 |
1 review(s) available for fulvestrant and moexipril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fulvestrant and moexipril
Article | Year |
---|---|
Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Combinations; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Heart; Isoquinolines; Myosin Heavy Chains; Organ Size; Ovariectomy; Protein Isoforms; Rats; Rats, Inbred SHR; RNA, Messenger; Tetrahydroisoquinolines; Up-Regulation | 2002 |